Literature DB >> 26699705

Culture-Based and Culture-Independent Bacteriologic Analysis of Cystic Fibrosis Respiratory Specimens.

Mona A Mahboubi1, Lisa A Carmody1, Bridget K Foster1, Linda M Kalikin1, Donald R VanDevanter2, John J LiPuma3.   

Abstract

Cystic fibrosis (CF) is characterized by chronic infection and inflammation of the airways. In vitro culture of select bacterial species from respiratory specimens has been used to guide antimicrobial therapy in CF for the past few decades. More recently, DNA sequence-based, culture-independent approaches have been used to assess CF airway microbiology, although the role that these methods will (or should) have in routine microbiologic analysis of CF respiratory specimens is unclear. We performed DNA sequence analyses to detect bacterial species in 945 CF sputum samples that had been previously analyzed by selective CF culture. We determined the concordance of results based on culture and sequence analysis, highlighting the comparison of the results for the most prevalent genera. Although overall prevalence rates were comparable between the two methods, results varied by genus. While sequence analysis was more likely to detect Achromobacter, Stenotrophomonas, and Burkholderia, it was less likely to detect Staphylococcus. Streptococcus spp. were rarely reported in culture results but were the most frequently detected species by sequence analysis. A variety of obligate and facultative anaerobic species, not reported by culture, was also detected with high prevalence by sequence analysis. Sequence analysis indicated that in a considerable proportion of samples, taxa not reported by selective culture constituted a relatively high proportion of the total bacterial load, suggesting that routine CF culture may underrepresent significant segments of the bacterial communities inhabiting CF airways.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26699705      PMCID: PMC4767965          DOI: 10.1128/JCM.02299-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities.

Authors:  Patrick D Schloss; Sarah L Westcott; Thomas Ryabin; Justine R Hall; Martin Hartmann; Emily B Hollister; Ryan A Lesniewski; Brian B Oakley; Donovan H Parks; Courtney J Robinson; Jason W Sahl; Blaz Stres; Gerhard G Thallinger; David J Van Horn; Carolyn F Weber
Journal:  Appl Environ Microbiol       Date:  2009-10-02       Impact factor: 4.792

Review 2.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

3.  Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection.

Authors:  Susse Kirkelund Hansen; Martin Holm Rau; Helle Krogh Johansen; Oana Ciofu; Lars Jelsbak; Lei Yang; Anders Folkesson; Hanne Østergaard Jarmer; Kasper Aanæs; Christian von Buchwald; Niels Høiby; Søren Molin
Journal:  ISME J       Date:  2011-06-30       Impact factor: 10.302

4.  Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.

Authors:  Vanja Klepac-Ceraj; Katherine P Lemon; Thomas R Martin; Martin Allgaier; Steven W Kembel; Alixandra A Knapp; Stephen Lory; Eoin L Brodie; Susan V Lynch; Brendan J M Bohannan; Jessica L Green; Brian A Maurer; Roberto Kolter
Journal:  Environ Microbiol       Date:  2010-02-23       Impact factor: 5.491

5.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

6.  Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients.

Authors:  Michael J Cox; Martin Allgaier; Byron Taylor; Marshall S Baek; Yvonne J Huang; Rebecca A Daly; Ulas Karaoz; Gary L Andersen; Ronald Brown; Kei E Fujimura; Brian Wu; Diem Tran; Jonathan Koff; Mary Ellen Kleinhenz; Dennis Nielson; Eoin L Brodie; Susan V Lynch
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

7.  Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.

Authors:  Michael M Tunney; Tyler R Field; Thomas F Moriarty; Sheila Patrick; Gerd Doering; Marianne S Muhlebach; Matthew C Wolfgang; Richard Boucher; Deirdre F Gilpin; Andrew McDowell; J Stuart Elborn
Journal:  Am J Respir Crit Care Med       Date:  2008-02-08       Impact factor: 21.405

8.  Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.

Authors:  D Worlitzsch; C Rintelen; K Böhm; B Wollschläger; N Merkel; M Borneff-Lipp; G Döring
Journal:  Clin Microbiol Infect       Date:  2009-01-22       Impact factor: 8.067

9.  Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens.

Authors:  Edith T Zemanick; Brandie D Wagner; Scott D Sagel; Mark J Stevens; Frank J Accurso; J Kirk Harris
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

10.  Culture enriched molecular profiling of the cystic fibrosis airway microbiome.

Authors:  Christopher D Sibley; Margot E Grinwis; Tyler R Field; Christina S Eshaghurshan; Monica M Faria; Scot E Dowd; Michael D Parkins; Harvey R Rabin; Michael G Surette
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

View more
  21 in total

Review 1.  The Yin and Yang of Streptococcus Lung Infections in Cystic Fibrosis: a Model for Studying Polymicrobial Interactions.

Authors:  Jessie E Scott; George A O'Toole
Journal:  J Bacteriol       Date:  2019-05-08       Impact factor: 3.490

Review 2.  Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice.

Authors:  Lindsay J Caverly; John J LiPuma
Journal:  Expert Rev Respir Med       Date:  2018-09-03       Impact factor: 3.772

3.  Analysis of airway microbiota in adults from a Brazilian cystic fibrosis center.

Authors:  Cassiana Costa Ferreira Leite; Flavia Alvim Dutra de Freitas; Mônica de Cássia Firmida; Robson Souza Leão; Rodolpho Mattos Albano; Elizabeth Andrade Marques
Journal:  Braz J Microbiol       Date:  2020-09-17       Impact factor: 2.476

4.  Microbial Interactions in the Cystic Fibrosis Airway.

Authors:  Ann M Granchelli; Frederick R Adler; Ruth H Keogh; Christiana Kartsonaki; David R Cox; Theodore G Liou
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

5.  Refining the Application of Microbial Lipids as Tracers of Staphylococcus aureus Growth Rates in Cystic Fibrosis Sputum.

Authors:  Cajetan Neubauer; Ajay S Kasi; Nora Grahl; Alex L Sessions; Sebastian H Kopf; Roberta Kato; Deborah A Hogan; Dianne K Newman
Journal:  J Bacteriol       Date:  2018-11-26       Impact factor: 3.490

6.  Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.

Authors:  Françoise Botterel; Cécile Angebault; Odile Cabaret; Franziska A Stressmann; Jean-Marc Costa; Frédéric Wallet; Benoit Wallaert; Kenneth Bruce; Laurence Delhaes
Journal:  Mycopathologia       Date:  2017-08-01       Impact factor: 2.574

7.  Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome.

Authors:  Maria T Nelson; Daniel J Wolter; Alexander Eng; Eli J Weiss; Anh T Vo; Mitchell J Brittnacher; Hillary S Hayden; Sumedha Ravishankar; Gilbert Bautista; Anina Ratjen; Marcella Blackledge; Sharon McNamara; Laura Nay; Cheryl Majors; Samuel I Miller; Elhanan Borenstein; Richard H Simon; John J LiPuma; Luke R Hoffman
Journal:  Thorax       Date:  2020-07-06       Impact factor: 9.139

8.  "Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis.

Authors:  Peter H Gilligan; Damian G Downey; J Stuart Elborn; Patrick A Flume; Sebastian Funk; Deirdre Gilpin; Timothy J Kidd; John McCaughan; B Cherie Millar; Philip G Murphy; Jacqueline C Rendall; Michael M Tunney; John E Moore
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

9.  Outcomes of cystic fibrosis pulmonary exacerbations treated with antibiotics with activity against anaerobic bacteria.

Authors:  Lauren M Castner; Madsen Zimbric; Shannon Cahalan; Corey Powell; Lindsay J Caverly
Journal:  J Cyst Fibros       Date:  2021-02-19       Impact factor: 5.482

10.  Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples.

Authors:  Lindsay J Caverly; Lisa A Carmody; Sarah-Jane Haig; Nadine Kotlarz; Linda M Kalikin; Lutgarde Raskin; John J LiPuma
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.